Leptin rs7799039 (G2548A) polymorphism is associated with cancer risk: a meta-analysis involving 25,799 subjects

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Garg SK, Maurer H, Reed K, Selagamsetty R. Diabetes and cancer: two diseases with obesity as a common risk factor. Diabetes Obes Metab. 2014;16(2):97–110. doi:10.1111/dom.2014.16.issue-223668396
   PubMed Web of Science ®Google Scholar
• Saxena NK, Sharma D, Ding X, et al. Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res. 2007;67(6):2497–2507. doi:10.1158/0008-5472.CAN-06-307517363567
   PubMed Web of Science ®Google Scholar
• Liang X, Wang S, Wang X, Zhang L, Zhao H, Zhang L. Leptin promotes the growth of breast cancer by upregulating the Wnt/beta-catenin pathway. Exp Ther Med. 2018;16(2):767–771. doi:10.3892/etm.2018.621230116331
   PubMed Web of Science ®Google Scholar
• Nwadozi E, Ng A, Stromberg A, et al. Leptin is a physiological regulator of skeletal muscle angiogenesis and is locally produced by PDGFRalpha and PDGFRbeta expressing perivascular cells. Angiogenesis. 2019;22(1):103–115. doi:10.1007/s10456-018-9641-6
   Google Scholar
• Sun X, Wei J, Tang Y, et al. Leptin-induced migration and angiogenesis in rheumatoid arthritis is mediated by reactive oxygen species. FEBS Open Bio. 2017;7(12):1899–1908.
   PubMed Web of Science ®Google Scholar
• Clements VK, Long T, Long R, Figley C, Smith DMC, Ostrand-Rosenberg S. Frontline science: high fat diet and leptin promote tumor progression by inducing myeloid-derived suppressor cells. J Leukoc Biol. 2018;103(3):395–407. doi:10.1002/JLB.4HI0517-210R29345342
   PubMed Web of Science ®Google Scholar
• Ray A, Cleary MP. The potential role of leptin in tumor invasion and metastasis. Cytokine Growth Factor Rev. 2017;38:80–97. doi:10.1016/j.cytogfr.2017.11.00229158066
   PubMed Web of Science ®Google Scholar
• Ye XL, Lu CF. Association of polymorphisms in the leptin and leptin receptor genes with inflammatory mediators in patients with osteoporosis. Endocrine. 2013;44(2):481–488. doi:10.1007/s12020-013-9899-923460508
   PubMed Web of Science ®Google Scholar
• Patraca I, Martinez N, Busquets O, et al. Anti-inflammatory role of Leptin in glial cells through p38 MAPK pathway inhibition. Pharmacol Rep. 2017;69(3):409–418. doi:10.1016/j.pharep.2016.12.00528273500
   PubMed Web of Science ®Google Scholar
• Santos CL, Bobermin LD, Souza DO, Quincozes-Santos A. Leptin stimulates the release of pro-inflammatory cytokines in hypothalamic astrocyte cultures from adult and aged rats. Metab Brain Dis. 2018. doi:10.1007/s11011-018-0311-6
   PubMed Web of Science ®Google Scholar
• Lu W, Zhou S, Xue L, et al. High preoperative serum leptin level is an independent risk factor for deep vein thrombosis after total knee arthroplasty in osteoarthritis patients: a prospective and cross-sectional study. Medicine. 2018;97(21):e10884. doi:10.1097/MD.000000000001088429794796
   PubMed Web of Science ®Google Scholar
• Petrini S, Neri T, Lombardi S, et al. Leptin induces the generation of procoagulant, tissue factor bearing microparticles by human peripheral blood mononuclear cells. Biochim Biophys Acta. 2016;1860(6):1354–1361. doi:10.1016/j.bbagen.2016.03.02927015759
   PubMed Web of Science ®Google Scholar
• Hardwick JC, Van Den Brink GR, Offerhaus GJ, Van Deventer SJ, Peppelenbosch MP. Leptin is a growth factor for colonic epithelial cells. Gastroenterology. 2001;121(1):79–90.11438496
   PubMed Web of Science ®Google Scholar
• Yuzhalin AE, Kutikhin AG. Integrative systems of genomic risk markers for cancer and other diseases: future of predictive medicine. Cancer Manag Res. 2012;4:131–135. doi:10.2147/CMAR.S3085522740773
   PubMedGoogle Scholar
• Yang J, Zhong Z, Tang W, Chen J. Leptin rs2167270 G > A (G19A) polymorphism may decrease the risk of cancer: A case-control study and meta-analysis involving 19 989 subjects. J Cell Biochem. 2019. doi:10.1002/jcb.28378
   Web of Science ®Google Scholar
• Terrasi M, Fiorio E, Mercanti A, et al. Functional analysis of the −2548G/A leptin gene polymorphism in breast cancer cells. Int J Cancer. 2009;125(5):1038–1044. doi:10.1002/ijc.2437219408304
   PubMed Web of Science ®Google Scholar
• Liu Y, Wu H, Zhu Y, Gao Y. Genetic association between leptin-2548G/A polymorphism and risk of cancer: a meta analysis. Int J Clin Exp Med. 2015;8(1):448–455.25785016
   PubMed Web of Science ®Google Scholar
• He J, Xi B, Ruiter R, et al. Association of LEP G2548A and LEPR Q223R polymorphisms with cancer susceptibility: evidence from a meta-analysis. PLoS One. 2013;8(10):e75135. doi:10.1371/journal.pone.007513524146750
   PubMed Web of Science ®Google Scholar
• Yang Y, Liu P, Guo F, et al. Genetic G2548A polymorphism of leptin gene and risk of cancer: a meta-analysis of 6860 cases and 7956 controls. J BUON. 2014;19(4):1096–1104.25536622
   PubMed Web of Science ®Google Scholar
• Kim EY, Chin HM, Park SM, et al. Susceptibility of gastric cancer according to leptin and leptin receptor gene polymorphisms in Korea. J Korean Surg Soc. 2012;83(1):7–13. doi:10.4174/jkss.2012.83.1.722792528
   PubMedGoogle Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–269, W264.19622511
   PubMed Web of Science ®Google Scholar
• Mantel NHW, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–748.13655060
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Bmj. 2003;327(7414):557–560. doi:10.1136/bmj.327.7414.55712958120
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188.3802833
   PubMedGoogle Scholar
• Ribeiro R, Vasconcelos A, Costa S, et al. Overexpressing leptin genetic polymorphism (−2548 G/A) is associated with susceptibility to prostate cancer and risk of advanced disease. Prostate. 2004;59(3):268–274. doi:10.1002/pros.2000415042602
   PubMed Web of Science ®Google Scholar
• Skibola CF, Holly EA, Forrest MS, et al. Body mass index, leptin and leptin receptor polymorphisms, and non-hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2004;13(5):779–786.15159310
   PubMed Web of Science ®Google Scholar
• Willett EV, Skibola CF, Adamson P, et al. Non-Hodgkin’s lymphoma, obesity and energy homeostasis polymorphisms. Br J Cancer. 2005;93(7):811–816. doi:10.1038/sj.bjc.660276216160698
   PubMed Web of Science ®Google Scholar
• Chovanec J, Bienertova-Vasku JA, Dostalova Z. Leptin–2548 g/A polymorphism in endometrial cancer. Klinicka. 2009;22(5):223–227.
   PubMedGoogle Scholar
• Moore SC, Leitzmann MF, Albanes D, et al. Adipokine genes and prostate cancer risk. Int J Cancer. 2009;124(4):869–876. doi:10.1002/ijc.2404319035456
   PubMed Web of Science ®Google Scholar
• Pechlivanis S, Bermejo JL, Pardini B, et al. Genetic variation in adipokine genes and risk of colorectal cancer. Eur j endocrinol. 2009;160(6):933–940. doi:10.1530/EJE-09-003919273568
   PubMed Web of Science ®Google Scholar
• Vasku A, Vokurka J, Bienertova-Vasku J. Obesity-related genes variability in Czech patients with sporadic colorectal cancer: preliminary results. Int J Colorectal Dis. 2009;24(3):289–294. doi:10.1007/s00384-008-0553-618704460
   PubMed Web of Science ®Google Scholar
• Cleveland RJ, Gammon MD, Long CM, et al. Common genetic variations in the LEP and LEPR genes, obesity and breast cancer incidence and survival. Breast Cancer Res Treat. 2010;120(3):745–752. doi:10.1007/s10549-009-0503-119697123
   PubMed Web of Science ®Google Scholar
• Ribeiro RJ, Monteiro CP, Azevedo AS, et al. Performance of an adipokine pathway-based multilocus genetic risk score for prostate cancer risk prediction. PLoS One. 2012;7(6):e39236. doi:10.1371/journal.pone.003923622792137
   PubMed Web of Science ®Google Scholar
• Tavil B, Balta G, Ergun EL, et al. Leptin promoter G-2548A genotypes and associated serum leptin levels in childhood acute leukemia at diagnosis and under high-dose steroid therapy. Leuk Lymphoma. 2012;53(4):648–653. doi:10.3109/10428194.2011.62688121955253
   PubMed Web of Science ®Google Scholar
• Unsal M, Kara N, Karakus N, Tural S, Elbistan M. Effects of leptin and leptin receptor gene polymorphisms on lung cancer. Tumour Biol. 2014;35(10):10231–10236. doi:10.1007/s13277-014-2293-225027400
   PubMed Web of Science ®Google Scholar
• Karakus N, Kara N, Ulusoy AN, Ozaslan C, Tural S, Okan I. Evaluation of CYP17A1 and LEP gene polymorphisms in breast cancer. Oncol Res Treat. 2015;38(9):418–422. doi:10.1159/00043894026407154
   PubMed Web of Science ®Google Scholar
• Mahmoudi R, Noori Alavicheh B, Nazer Mozaffari MA, Fararouei M, Nikseresht M. Polymorphisms of leptin (−2548 G/A) and leptin receptor (Q223R) genes in Iranian women with breast cancer. Int J Genomics. 2015;2015:132720. doi:10.1155/2015/13272026199932
   PubMed Web of Science ®Google Scholar
• Mohammadzadeh G, Ghaffari MA, Bafandeh A, Hosseini SM, Ahmadi B. The relationship between −2548 G/A leptin gene polymorphism and risk of breast cancer and serum leptin levels in Ahvazian women. Iran J Cancer Prev. 2015;8(2):100–108.25960849
   PubMed Web of Science ®Google Scholar
• Rostami S, Kohan L, Mohammadianpanah M. The LEP G-2548A gene polymorphism is associated with age at menarche and breast cancer susceptibility. Gene. 2015;557(2):154–157. doi:10.1016/j.gene.2014.12.02125510398
   PubMed Web of Science ®Google Scholar
• Mahmoudi T, Farahani H, Nobakht H, Dabiri R, Zali MR. Genetic variations in leptin and leptin receptor and susceptibility to colorectal cancer and obesity. Iran J Cancer Prev. 2016;9(3):e7013.27703650
   PubMedGoogle Scholar
• Amer T, El-Baz R, Mokhtar AR, El-Shaer S, Elshazli R, Settin A. Genetic polymorphisms of IL-23R (rs7517847) and LEP (rs7799039) among Egyptian patients with hepatocellular carcinoma. Arch Physiol Biochem. 2017;123(5):279–285. doi:10.1080/13813455.2017.132068028452232
   PubMed Web of Science ®Google Scholar
• Ali SHB, Bangash KS, Rauf A, et al. Identification of novel potential genetic predictors of urothelial bladder carcinoma susceptibility in Pakistani population. Fam Cancer. 2017;16(4):577–594. doi:10.1007/s10689-017-9991-z28386678
   PubMed Web of Science ®Google Scholar
• Rodrigo C, Tennekoon KH, Karunanayake EH, De Silva K, Amarasinghe I, Wijayasiri A. Circulating leptin, soluble leptin receptor, free leptin index, visfatin and selected leptin and leptin receptor gene polymorphisms in sporadic breast cancer. Endocr J. 2017;64(4):393–401. doi:10.1507/endocrj.EJ16-044828190851
   PubMed Web of Science ®Google Scholar
• Zhang S, Jiang J, Chen Z, et al. Investigation of LEP and LEPR polymorphisms with the risk of hepatocellular carcinoma: a case-control study in Eastern Chinese Han population. Onco Targets Ther. 2018;11:2083–2089. doi:10.2147/OTT.S15393129695916
   PubMed Web of Science ®Google Scholar
• Hussain SR, Naqvi H, Gupta S, et al. A study on oncogenic role of leptin and leptin receptor in oral squamous cell. Tumour Biol. 2015;36(8):6515–6523. doi:10.1007/s13277-015-3342-125809704
   PubMedGoogle Scholar
• Qiu H, Lin X, Tang W, et al. Investigation of TCF7L2, LEP and LEPR polymorphisms with esophageal squamous cell carcinomas. Oncotarget. 2017;8(65):109107–109119. doi:10.18632/oncotarget.2261929312594
   PubMedGoogle Scholar
• Yuan XL, Xu ZP, Liu CR, et al. [Study of the association between polymorphism of persistent obesity, human leptin gene/leptin receptor gene and molecular subtypes of breast cancer]. Zhonghua Yu Fang Yi Xue Za Zhi. 2017;51(6):533–538. doi:10.3760/cma.j.issn.0253-9624.2017.06.01528592099
   PubMedGoogle Scholar
• Liu CR, Li Q, Hou C, et al. Changes in body mass index, leptin, and leptin receptor polymorphisms and breast cancer risk. DNA Cell Biol. 2018;37(3):182–188. doi:10.1089/dna.2017.404729336592
   PubMed Web of Science ®Google Scholar
• Zhang J, Dhakal IB, Zhang X, Prizment AE, Anderson KE. Genetic variability in energy balance and pancreatic cancer risk in a population-based case-control study in Minnesota. Pancreas. 2014;43(2):281–286. doi:10.1097/MPA.0b013e3182a7c82924201779
   PubMed Web of Science ®Google Scholar
• Snoussi K, Strosberg AD, Bouaouina N, Ben Ahmed S, Helal AN, Chouchane L. Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma. BMC Cancer. 2006;6:38. doi:10.1186/1471-2407-6-3816504019
   PubMed Web of Science ®Google Scholar
• Slattery ML, Wolff RK, Herrick J, Caan BJ, Potter JD. Leptin and leptin receptor genotypes and colon cancer: gene-gene and gene-lifestyle interactions. Int J Cancer. 2008;122(7):1611–1617. doi:10.1002/ijc.2313518059035
   PubMed Web of Science ®Google Scholar
• Luan H, Zhang H, Li Y, et al. Association of two obesity-related gene polymorphisms LEPG2548A rs7799039 and LEPRQ223R rs1137101 with the risk of breast cancer. Oncotarget. 2017;8(35):59333–59344. doi:10.18632/oncotarget.1958028938640
   PubMedGoogle Scholar
• Cao FJWG, Yu YD, Yu XJ, Die QS, Lei JH, Deng SH. Chen P association of leptin gene −2548 G/A polymorphism with the susceptibility and prognosis of non-small cell lung cancer. Chin J Exp Surg. 2015;32(3):621–623.
   Google Scholar
• Hoffstedt J, Eriksson P, Mottagui-Tabar S, Arner P. A polymorphism in the leptin promoter region (−2548 G/A) influences gene expression and adipose tissue secretion of leptin. Horm Metab Res. 2002;34(7):355–359. doi:10.1055/s-2002-3346612189581
   PubMed Web of Science ®Google Scholar